Gene · 25823
Papers1,522
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,522
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurobiological mechanisms of ECT and TMS treatment in depression: study protocol of a multimodal magnetic resonance investigation. | BMC Psychiatry | 2023 | 37904091 | PubTator, text mining | PubMed |
| Impact of employment on the elderly in a super-aging society during the COVID-19 pandemic in Japan. | Sci Rep | 2023 | 37903962 | PubTator, text mining | PubMed |
| Interaction of Calmodulin with TRPM: An Initiator of Channel Modulation. | Int J Mol Sci | 2023 | 37894842 | PubTator, text mining | PubMed |
| TRP Channels in Cancer: Signaling Mechanisms and Translational Approaches. | Biomolecules | 2023 | 37892239 | PubTator, text mining | PubMed |
| lesSDRF is more: maximizing the value of proteomics data through streamlined metadata annotation. | Nat Commun | 2023 | 37875519 | PubTator, text mining | PubMed |
| Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease. | PLoS One | 2023 | 37874822 | PubTator, text mining | PubMed |
| Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma. | Nat Commun | 2023 | 37872167 | PubTator, text mining | PubMed |
| Recent Advances in Understanding the Mechanistic Role of Transient Receptor Potential Ion Channels in Patients With Hypertension. | Can J Cardiol | 2023 | 37865227 | PubTator, text mining | PubMed |
| Elucidating regulatory processes of intense physical activity by multi-omics analysis. | Mil Med Res | 2023 | 37853489 | PubTator, text mining | PubMed |
| Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7. | Front Cell Dev Biol | 2023 | 37842082 | PubTator, text mining | PubMed |
| A review of the pathophysiology and the role of ion channels on bronchial asthma. | Front Pharmacol | 2023 | 37841931 | PubTator, text mining | PubMed |
| Modified activities of macrophages' deubiquitinating enzymes after Francisella infection. | Front Immunol | 2023 | 37841261 | PubTator, text mining | PubMed |
| An Automated Nanowell-Array Workflow for Quantitative Multiplexed Single-Cell Proteomics Sample Preparation at High Sensitivity. | Mol Cell Proteomics | 2023 | 37839701 | PubTator, text mining | PubMed |
| Recent Developments in Ion Channel and Ion-Related Signaling. | Int J Mol Sci | 2023 | 37833868 | PubTator, text mining | PubMed |
| Effects of exergaming on executive functions of children: a systematic review and meta-analysis from 2010 to 2023. | Arch Public Health | 2023 | 37833741 | PubTator, text mining | PubMed |
A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO). | Pilot Feasibility Stud | 2023 | 37828592 | PubTator, text mining | PubMed |
| Strongyloides stercoralis infection reduces Fusicatenibacter and Anaerostipes in the gut and increases bacterial amino-acid metabolism in early-stage chronic kidney disease. | Heliyon | 2023 | 37809389 | PubTator, text mining | PubMed |
| Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma. | Front Oncol | 2023 | 37799465 | PubTator, text mining | PubMed |
| The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin. | Cell Commun Signal | 2023 | 37798768 | PubTator, text mining | PubMed |
| FAM111A regulates replication origin activation and cell fitness. | Life Sci Alliance | 2023 | 37793778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25823/papers?page=9